Micro-Navigation:

News

Fresenius Medical Care announces encouraging results of CALMAG study on phosphate binder OsvaRen® at the 2010 EDTA congress in Munich

23. Jun 2010 |  more

Events

39. International EDTNA/ERCA Conference 2010 – Renal Pharma Corporate Education Session: Read more!

31. Aug 2010  | more

Macro-Navigation:

Imprint

Published by
Fresenius Medical Care Deutschland GmbH,
which is represented by its Managing Directors: Roberto Fusté, Dr. Emanuele Gatti, Dr. Angelo Mößlang, Eberhard Sieger

Edited by
Fresenius Medical Care Deutschland GmbH
Renal Pharma
Else-Kröner-Straße 1
61352 Bad Homburg
Germany

Tel.:++49 6172 609 0
Fax:++49 6172 609 5638
Email: renalpharma@fmc-ag.com

District Court: Bad Homburg, HRB 5748
Identification number for turnover tax: DE 812033564